Transcriptional activation of human mu-opioid receptor gene by insulin-like growth factor-I in neuronal cells is modulated by the transcription factor REST

Journal of Neurochemistry

Volumn 105, Issue 6, 2008, Pages 2166-2178

  Bedini, Andrea ^a   Baiula, Monica ^a   Spampinato, Santi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Insulin like growth factor I; Mu opioid receptor; Neuroblastoma; Repressor element 1 silencing transcription factor; Signal transducer and activator of transcription 3; Transcriptional repression

Indexed keywords

MU OPIATE RECEPTOR; REPRESSOR ELEMENT 1 SILENCING TRANSCRIPTION FACTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE SWITCHING; HUMAN; HUMAN CELL; NERVE CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA-BINDING PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEUROBLASTOMA; NEURONS; PC12 CELLS; PROTEIN BINDING; RATS; RECEPTORS, OPIOID, MU; REPRESSOR PROTEINS; TRANSCRIPTIONAL ACTIVATION; TRETINOIN; UP-REGULATION;

EID: 44649095666     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05303.x     Document Type: Article

References (52)

1. Andria M. L. Simon E. J. (2001) Identification of a neurorestrictive suppressor element (NRSE) in the human mu-opioid receptor gene. Brain Res. Mol. Brain Res. 91, 73 80.
2. Arsenijevic Y. Weiss S. (1998) Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor. J. Neurosci. 18, 2118 2128.
3. Bai G., Zhuang Z., Liu A., Chai Y. Hoffman P. W. (2003) The role of the RE1 element in activation of the NR1 promoter during neuronal differentiation. J. Neurochem. 86, 992 1005.
4. Ballas N. Mandel G. (2005) The many faces of REST oversee epigenetic programming of neuronal genes. Curr. Opin. Neurobiol. 15, 500 506.
5. Ballas N., Battaglioli E., Atouf F. et al. (2001) Regulation of neuronal traits by a novel transcriptional complex. Neuron 31, 353 365.
6. Ballas N., Grunseich C., Lu D. D., Speh J. C. Mandel G. (2005) REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121, 645 657.
7. Battaglioli E., Andres M. E., Rose D. W., Chenoweth J. G., Rosenfeld M. G., Anderson M. E. Mandel G. (2002) REST repression of neuronal genes requires components of the hSWI.SNF complex. J. Biol. Chem. 277, 41038 41045.
8. Bondy C. A. Cheng C. M. (2004) Signaling by insulin-like growth factor 1 in brain. Eur. J. Pharmacol. 490, 25 31.
9. Borner C., Hollt V. Kraus J. (2002) Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene. Mol. Pharmacol. 61, 800 805.
10. Borner C., Kraus J., Schroder H., Ammer H. Hollt V. (2004) Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6. Mol. Pharmacol. 66, 1719 1726.
11. Bruce A. W., Krejci A., Ooi L., Deuchars J., Wood I. C., Dolezal V. Buckley N. J. (2006) The transcriptional repressor REST is a critical regulator of the neurosecretory phenotype. J. Neurochem. 98, 1828 1840.
12. Calderone A., Jover T., Noh K. M. et al. (2003) Ischemic insults derepress the gene silencer REST in neurons destined to die. J. Neurosci. 23, 2112 2121.
13. Chen H. C., Wei L. N. Loh H. H. (1999) Expression of mu-, kappa- and delta-opioid receptors in P19 mouse embryonal carcinoma cells. Neuroscience 92, 1143 1155.
14. Coulson J. M. (2005) Transcriptional regulation: cancer, neurons and the REST. Curr. Biol. 15, R665 R668.
15. Di Toro R., Baiula M. Spampinato S. (2005) Expression of the repressor element-1 silencing transcription factor (REST) is influenced by insulin-like growth factor-I in differentiating human neuroblastoma cells. Eur. J. Neurosci. 21, 46 58.
16. Formisano L., Noh K. M., Miyawaki T., Mashiko T., Bennett M. V. Zukin R. S. (2007) Ischemic insults promote epigenetic reprogramming of mu opioid receptor expression in hippocampal neurons. Proc. Natl Acad. Sci. USA 104, 4170 4175.
17. Giannini G., Dawson M. I., Zhang X. Thiele C. J. (1997) Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells. J. Biol. Chem. 272, 26693 26701.
18. van Golen C. M. Feldman E. L. (2000) Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J. Cell. Physiol. 182, 24 32.
19. Harburg G. C., Hall F. S., Harrist A. V., Sora I., Uhl G. R. Eisch A. J. (2007) Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons. Neuroscience 144, 77 87.
20. Hohl M. Thiel G. (2005) Cell type-specific regulation of RE1 silencing transcription factor (REST) target genes. Eur. J. Neurosci. 22, 2216 2230.
21. Howard M. J. (2005) Mechanisms and perspectives on differentiation of autonomic neurons. Dev. Biol. 277, 271 286.
22. Jenab S. Inturrisi C. E. (2002) Retinoic acid regulation of mu opioid receptor and c-fos mRNAs and AP-1 DNA binding in SH-SY5Y neuroblastoma cells. Brain Res. Mol. Brain Res. 99, 34 39.
23. Joshi S., Guleria R., Pan J., DiPette D. Singh U. S. (2006) Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells. Oncogene 25, 240 247.
24. Kim C. S., Hwang C. K., Choi H. S., Song K. Y., Law P. Y., Wei L. N. Loh H. H. (2004) Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J. Biol. Chem. 279, 46464 46473.
25. Kivell B. M., Day D. J., McDonald F. J. Miller J. H. (2004) Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats. Brain Res. Dev. Brain Res. 149, 9 19.
26. Kraus J., Borner C. Hollt V. (2003a) Distinct palindromic extensions of the 5′-TTC...GAA-3′ motif allow STAT6 binding in vivo. FASEB J. 17, 304 306.
27. Kraus J., Borner C., Giannini E. Hollt V. (2003b) The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol. Pharmacol. 64, 876 884.
28. Law P. Y., Loh H. H. Wei L. N. (2004) Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology 47 (Suppl. 1 300 311.
29. Lichtenwalner R. J., Forbes M. E., Sonntag W. E. Riddle D. R. (2006) Adult-onset deficiency in growth hormone and insulin-like growth factor-I decreases survival of dentate granule neurons: insights into the regulation of adult hippocampal neurogenesis. J. Neurosci. Res. 83, 199 210.
30. Lunyak V. V., Prefontaine G. G. Rosenfeld M. G. (2004) REST and peace for the neuronal-specific transcriptional program. Ann. NY Acad. Sci. 1014, 110 120.
31. Ma Q. (2006) Transcriptional regulation of neuronal phenotype in mammals. J. Physiol. 575, 379 387.
32. Mayer P. Hollt V. (2006) Pharmacogenetics of opioid receptors and addiction. Pharmacogenet. Genomics 16, 1 7.
33. Munson P. J. Rodbard D. (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Ann. Biochem. 107, 220 239.
34. Okamoto S., Sherman K. Lipton S. A. (1999) Absence of binding activity of neuron-restrictive silencer factor is necessary, but not sufficient for transcription of NMDA receptor subunit type 1 in neuronal cells. Brain Res. Mol. Brain Res. 74, 44 54.
35. Pahlman S., Mamaeva S., Meyerson G., Mattsson M. E., Bjelfman C., Ortoft E. Hammerling U. (1990) Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol. Scand. Suppl. 592, 25 37.
36. Palm K., Belluardo N., Metsis M. Timmusk T. (1998) Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene. J. Neurosci. 18, 1280 1296.
37. Pollock J. D., Krempin M. Rudy B. (1990) Differential effects of NGF, FGF, EGF, cAMP, and dexamethasone on neurite outgrowth and sodium channel expression in PC12 cells. J. Neurosci. 10, 2626 2637.
38. Reich N. C. Liu L. (2006) Tracking STAT nuclear traffic. Nat. Rev. Immunol. 6, 602 612.
39. Schoenherr C. J., Paquette A. J. Anderson D. J. (1996) Identification of potential target genes for the neuron-restrictive silencer factor. Proc. Natl Acad. Sci. USA 93, 9881 9886.
40. Singh U. S., Pan J., Kao Y. L., Joshi S., Young K. L. Baker K. M. (2003) Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Biol. Chem. 278, 391 399.
41. Spencer E. M., Chandler K. E., Haddley K. et al. (2006) Regulation and role of REST and REST4 variants in modulation of gene expression in vivo and in vitro in epilepsy models. Neurobiol. Dis. 24, 41 52.
42. Su X., Kameoka S., Lentz S. Majumder S. (2004) Activation of REST/NRSF target genes in neural stem cells is sufficient to cause neuronal differentiation. Mol. Cell. Biol. 24, 8018 8025.
43. Sun Y. M., Greenway D. J., Johnson R., Street M., Belyaev N. D., Deuchars J., Bee T., Wilde S. Buckley N. J. (2005) Distinct profiles of REST interactions with its target genes at different stages of neuronal development. Mol. Biol. Cell 16, 5630 5638.
44. Vincent A. M. Feldman E. L. (2002) Control of cell survival by IGF signaling pathways. Growth Horm. IGF Res. 12, 193 197.
45. Winer J., Jung C. K., Shackel I. Williams P. M. (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270, 41 49.
46. Winzer-Serhan U. H., Chen Y. Leslie F. M. (2003) Expression of opioid peptides and receptors in striatum and substantia nigra during rat brain development. J. Chem. Neuroanat. 26, 17 36.
47. Wood I. C., Roopra A. Buckley N. J. (1996) Neural specific expression of the m4 muscarinic acetylcholine receptor gene is mediated by a RE1/NRSE-type silencing element. J. Biol. Chem. 271, 14221 14225.
48. Xu Y. Carr L. G. (2001) Binding of Sp1/Sp3 to the proximal promoter of the hMOR gene is enhanced by DAMGO. Gene 274, 119 128.
49. Yadav A., Kalita A., Dhillon S. Banerjee K. (2005) JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3. J. Biol. Chem. 280, 31830 31840.
50. Yu V. C. Sadee W. (1988) Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells. J. Pharmacol. Exp. Ther. 245, 350 355.
51. Zollner C. Stein C. (2007) Opioids. Handb. Exp. Pharmacol. 177, 31 63.
52. Zong C. S., Chan J., Levy D. E., Horvath C., Sadowski H. B. Wang L. H. (2000) Mechanism of STAT3 activation by insulin-like growth factor I receptor. J. Biol. Chem. 275, 15099 15105.